Palbolieva 125mg Capsule: Maximum Potency CDK4/6 Inhibition for Advanced HR+/HER2- Breast Cancer Care Are you searching for a verified Palbolieva 125mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced targeted breast cancer therapies. We provide a secure, high-standard supply chain for London & the UK, the USA, Australia, and South Africa, ensuring that high-dose cyclin-dependent kinase inhibitors reach oncology centers with 100% pharmaceutical integrity. Detailed Product Profile: What is Palbolieva 125mg? Palbolieva 125mg is an oral targeted chemotherapy medication containing the active pharmaceutical ingredient Palbociclib. Manufactured by Allieva, the 125mg strength is the standard therapeutic starting dose for most patients. It belongs to a revolutionary class of drugs called CDK4/6 inhibitors, designed to specifically block the proteins that drive the rapid division of hormone-receptor-positive breast cancer cells. 1. Therapeutic Indications HR+, HER2- Metastatic Breast Cancer: For patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that has spread. Initial Endocrine-Based Therapy: Often prescribed in combination with an aromatase inhibitor (like Letrozole or Anastrozole) as a first-line treatment for postmenopausal women or men. Progressive Disease Therapy: Used in combination with Fulvestrant for patients whose cancer has progressed after prior endocrine therapy. 2. Mechanism of Action: Arresting the Malignant Cell Cycle Kinase Blockade: It selectively inhibits Cyclin-Dependent Kinases 4 and 6 (CDK4/6). In many breast cancers, these kinases are overactive, pushing cells to divide uncontrollably. G1-Phase Arrest: By blocking these enzymes, Palbolieva prevents the cancer cell from moving from the growth phase (G1) to the DNA replication phase (S). Halting Proliferation: This results in “cell cycle arrest,“ which stabilizes the tumor, reduces its size, and significantly extends progression-free survival (PFS). 3. Administration and Dosing Schedule Standard Regimen: Typically administered in a 28-day cycle—one 125mg capsule daily for 21 consecutive days, followed by 7 days of rest. Bioavailability: Palbolieva 125mg should be taken with food at approximately the same time each day to ensure the drug is absorbed correctly by the body. Handling: Capsules must be swallowed whole; they should not be opened, crushed, or chewed. Clinical Side Effects & Safety Monitoring Neutropenia: A significant decrease in white blood cells (neutrophils) is common. Regular complete blood counts (CBC) are mandatory before starting each cycle. Infection Risk: Due to lower blood counts, patients must monitor for signs of fever or chills. Gastrointestinal: Nausea, diarrhea, and mouth sores (stomatitis) are frequently observed. General Fatigue: Significant tiredness or lack of energy is a known clinical side effect. Dermatological: Potential for thinning of the hair (alopecia) or dry skin. Drug Interactions: Avoid grapefruit products and certain herbal supplements like St. John’s Wort, as they can alter the drug's efficacy and toxicity levels. Why Source Palbolieva 125mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva’s Palbolieva with full batch-specific traceability and COA. Logistics Authority: Expert handling of complex import regulations for London (UK), the USA, Australia, and South Africa. Bulk Supply Solutions: Competitive wholesale pricing for hospital groups, specialty oncology pharmacies, and regional distributors. Regulatory Compliance: Every shipment is accompanied by GMP certificates and complete B2B documentation. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: Chat on WhatsApp
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us